Association of serum and intratumoral cytokine profiles with tumor stage and neutrophil lymphocyte ratio in colorectal cancer

Anticancer Research

Volumn 34, Issue 7, 2014, Pages 3481-3487

  Kim, Young Wan ^a   Kim, Soo Ki ^a   Kim, Cheol Su ^a   Kim, Ik Yong ^a   Cho, Mee Yon ^a   Kim, Nam Kyu ^b  

^a Yonsei University Wonju College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

Colorectal cancer; Cytokine; IL6; IL8; Multiplex assay; Vascular endothelial growth factor

Indexed keywords

CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CANCER STAGING; CANCER TISSUE; CLINICAL ARTICLE; COLORECTAL CANCER; FEMALE; HUMAN; HUMAN TISSUE; LYMPHOCYTE; MACROPHAGE; MALE; MUCOSA; NEUTROPHIL; NEUTROPHIL LYMPHOCYTE RATIO; BLOOD; COLORECTAL TUMOR; IL6; IL8; IMMUNOLOGY; INTESTINE MUCOSA; LYMPHOCYTE SUBPOPULATION; MIDDLE AGED; MULTIPLEX ASSAY; PATHOLOGY; PROSPECTIVE STUDY;

COLORECTAL CANCER; CYTOKINE; IL6; IL8; MULTIPLEX ASSAY; VASCULAR ENDOTHELIAL GROWTH FACTOR;

AGED; COLORECTAL NEOPLASMS; CYTOKINES; FEMALE; HUMANS; INTESTINAL MUCOSA; LYMPHOCYTE SUBSETS; LYMPHOCYTES; MALE; MIDDLE AGED; NEOPLASM STAGING; NEUTROPHILS; PROSPECTIVE STUDIES;

EID: 84906327199     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Proctor MJ, Talwar D, Balmar SM, O'Reilly DS, Foulis AK, Horgan PG, Morrison DS and McMillan DC: The relationship between the presence and site of cancer, an inflammation-based prognostic score and biochemical parameters. Initial results of the Glasgow Inflammation Outcome Study. Br J Cancer 103(6): 870-876, 2010.
2. Hung HY, Chen JS, Yeh CY, Changchien CR, Tang R, Hsieh PS, Tasi WS, You JF, You YT, Fan CW, Wang JY and Chiang JM: Effect of preoperative neutrophil-lymphocyte ratio on the surgical outcomes of stage II colon cancer patients who do not receive adjuvant chemotherapy. Int J Colorectal Dis 26(8): 1059-1065, 2011.
3. Jass JR, Love SB and Northover JM: A new prognostic classification of rectal cancer. Lancet 1(8545): 1303-1306, 1987.
4. Galon J, Fridman WH and Pages F: The adaptive immunologic microenvironment in colorectal cancer: a novel perspective. Cancer Res 67(5): 1883-1886, 2007.
5. Fridman WH, Pages F, Sautes-Fridman C and Galon J: The immune contexture in human tumours: impact on clinical outcome. Nat Rev Cancer 12(4): 298-306, 2012.
6. Kantola T, Klintrup K, Vayrynen JP, Vornanen J, Bloigu R, Karhu T, Herzig KH, Napankangas J, Makela J, Karttunen TJ, Tuomisto A and Makinen MJ: Stage-dependent alterations of the serum cytokine pattern in colorectal carcinoma. Br J Cancer 107(10): 1729-1736, 2012.
7. Krzystek-Korpacka M, Diakowska D, Kapturkiewicz B, Bebenek M and Gamian A: Profiles of circulating inflammatory cytokines in colorectal cancer (CRC), high cancer risk conditions, and health are distinct. Possible implications for CRC screening and surveillance. Cancer Lett 337(1): 107-114, 2013.
8. van der Wilt CL, Smid K, Aherne GW, Noordhuis P and Peters GJ: Biochemical mechanisms of interferon modulation of 5-fluorouracil activity in colon cancer cells. Eur J Cancer 33(3): 471-478, 1997.
9. Enzler T, Gillessen S, Manis JP, Ferguson D, Fleming J, Alt FW, Mihm M and Dranoff G: Deficiencies of GM-CSF and interferon gamma link inflammation and cancer. J Exp Med 197(9): 1213-1219, 2003.
10. Wakimoto H, Abe J, Tsunoda R, Aoyagi M, Hirakawa K and Hamada H: Intensified antitumor immunity by a cancer vaccine that produces granulocyte-macrophage colony-stimulating factor plus interleukin 4. Cancer Res 56(8): 1828-1833, 1996.
11. Toi M, Bicknell R and Harris AL: Inhibition of colon and breast carcinoma cell growth by interleukin-4. Cancer Res 52(2): 275-279, 1992.
12. Terzic J, Grivennikov S, Karin E and Karin M: Inflammation and colon cancer. Gastroenterology 138(6): 2101-2114.e2105, 2010.
13. Chung YC and Chang YF: Serum interleukin-6 levels reflect the disease status of colorectal cancer. J Surg Oncol 83(4): 222-226, 2003.
14. Ueda T, Shimada E and Urakawa T: Serum levels of cytokines in patients with colorectal cancer: possible involvement of interleukin-6 and interleukin-8 in hematogenous metastasis. J Gastroenterol 29(4): 423-429, 1994.
15. Cacev T, Radosevic S, Krizanac S and Kapitanovic S: Influence of interleukin-8 and interleukin-10 on sporadic colon cancer development and progression. Carcinogenesis 29(8): 1572-1580, 2008.
16. Ellis LM, Takahashi Y, Liu W and Shaheen RM: Vascular endothelial growth factor in human colon cancer: biology and therapeutic implications. Oncologist 5(Suppl 1) : 11-15, 2000.
17. Fulton RJ, McDade RL, Smith PL, Kienker LJ and Kettman JR, Jr.: Advanced multiplexed analysis with the FlowMetrix system. Clin Chem 43(9): 1749-1756, 1997.
18. Lee KS, Chung JH, Lee KH, Shin MJ, Oh BH and Hong CH: Bioplex analysis of plasma cytokines in Alzheimer's disease and mild cognitive impairment. Immunol Lett 121(2): 105-109, 2008.
19. Edge SB and Compton CC: The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 17(6): 1471-1474, 2010.
20. Kuchtey J, Rezaei KA, Jaru-Ampornpan P, Sternberg P, Jr. and Kuchtey RW: Multiplex cytokine analysis reveals elevated concentration of interleukin-8 in glaucomatous aqueous humor. Invest Ophthalmol Vis Sci 51(12): 6441-6447, 2010.
21. Ramsey S, Lamb GW, Aitchison M and McMillan DC: The longitudinal relationship between circulating concentrations of C-reactive protein, interleukin-6 and interleukin-10 in patients undergoing resection for renal cancer. Br J Cancer 95(8): 1076-1080, 2006.
22. Guthrie GJ, Roxburgh CS, Horgan PG and McMillan DC: Does interleukin-6 link explain the link between tumour necrosis, local and systemic inflammatory responses and outcome in patients with colorectal cancer? Cancer Treat Rev 39(1): 89-96, 2013.
23. Banyer JL, Hamilton NH, Ramshaw IA and Ramsay AJ: Cytokines in innate and adaptive immunity. Rev Immunogenet 2(3): 359-373, 2000.
24. Esfandi F, Mohammadzadeh Ghobadloo S and Basati G: Interleukin-6 level in patients with colorectal cancer. Cancer Lett 244(1): 76-78, 2006.
25. Dranoff G: GM-CSF-based cancer vaccines. Immunol Rev 188: 147-154, 2002.
26. Takeda K, Hatakeyama K, Tsuchiya Y, Rikiishi H and Kumagai K: A correlation between GM-CSF gene expression and metastases in murine tumors. Int J Cancer 47(3): 413-420, 1991.
27. Kuniyasu H, Yasui W, Shinohara H, Yano S, Ellis LM, Wilson MR, Bucana CD, Rikita T, Tahara E and Fidler IJ: Induction of angiogenesis by hyperplastic colonic mucosa adjacent to colon cancer. Am J Pathol 157(5): 1523-1535, 2000.
28. De Vita F, Orditura M, Lieto E, Infusino S, Morgillo F, Martinelli E, Castellano P, Romano C, Ciardiello F, Catalano G, Pignatelli C and Galizia G: Elevated perioperative serum vascular endothelial growth factor levels in patients with colon carcinoma. Cancer 100(2): 270-278, 2004.